| Gene symbol | MS4A1 | Synonyms | B1, Bp35, CD20, CVID5, FMC7, LEU-16, S7 | Type of gene | protein-coding |
| Chromosome | 11 | Map location | 11q12.2 | dbXrefs | |
| Description | membrane spanning 4-domains A1 | ||||
| GTO ID | GTC1112 |
| Trial ID | JPRN-jRCT1080224690 |
| Disease | B-Cell Non-Hodgkin's Lymphoma |
| Altered gene | CD20 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | FCAR-CD20 |
| Phase | Phase1 |
| Recruitment status | Not Recruiting |
| Title | Phase I study of FCAR-CD20 therapy in patients with refractory CD20-positive B-cell non-Hodgkin lymphoma |
| Year | 2019 |
| Country | Japan |
| Company sponsor | National Cancer Center Hospital East |
| Other ID(s) | JapicCTI-194764 |
| Cohort 1 | |||||||
|
|||||||